HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Y-mAbs
SAN FRANCISCO, March 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
Globe Newswire12-03-2023, 04:01
MGA Entertainment Establishes Four Subsidiaries to Support its Fast Growing International Business in the European Union 1-02-2024, 15:15